Akin Advises Pharmakon in its $646 Million Secured Financing to Fund Collegium’s Acquisition of Ironshore Therapeutics
Contact:
(New York) – Akin advised Pharmakon Advisors, LP and its affiliated funds in providing Collegium Pharmaceutical with a $646 million secured financing to be used to help fund Collegium’s acquisition of Ironshore Therapeutics Inc., a privately held, pharmaceutical company that markets and distributes Jornay PM®, a central nervous system stimulant prescription medicine for the treatment of attention deficit hyperactivity disorder. The new five-year term loan replaces the existing Collegium term loan from Pharmakon.
The Akin team was led by tax partner Geoffrey Secol, and included counsel Ekaterina Lyashenko and associate Jake Gawlak.
For more information on the transaction, please click here.
Akin is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.
# # #
